// App-Quantinova.ai

: Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies

Researchers

Presenter

  • Caner Saygin

Principal Investigators

  • Christopher N Hahn

  • Rakchha Chhetri

  • Saar Gill

  • Hany Elmariah

  • Chetasi Talati

  • Emma Nunley

  • Guimin Gao

  • Aelin Kim

  • Michael R. Bishop

  • Satyajit Kosuri

  • Soma Das

  • Deepak Singhal

  • Parvathy Venugopal

  • Claire Homan

  • Anna L. Brown

  • Hamish S Scott

  • Devendra Hiwase

  • Lucy A. Godley

Medical Centers

  • Adelaide Medical School, University of Adelaide, Adelaide, Australia

  • University of Chicago Department of Informatics and Biostatistics, Chicago, IL

  • Moffitt Cancer Center, Tampa, FL

  • Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL

  • The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

  • Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia

  • Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

  • Department of Human Genetics, The University of Chicago, Chicago, IL

  • Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia

  • Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

  • Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia

  • Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

  • University of Chicago Section of Hematology/Oncology, Chicago, IL

Locations

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

  • Solid malignancies

Biomarkers

  • checkpoint kinase 2

  • Apparent diffusion coefficient

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A


Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A